{"id":"NCT01445678","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","briefTitle":"Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections","officialTitle":"A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Efficacy and Safety of Intravenous CXA-201 With That of Meropenem in Complicated Intraabdominal Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12-23","primaryCompletion":"2013-10-03","completion":"2013-10-15","firstPosted":"2011-10-04","resultsPosted":"2015-01-15","lastUpdate":"2018-11-16"},"enrollment":494,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Complicated Intra-abdominal Infection"],"interventions":[{"type":"DRUG","name":"CXA-201 and metronidazole","otherNames":[]},{"type":"DRUG","name":"Meropenem","otherNames":[]}],"arms":[{"label":"CXA-201 and Metronidazole as treatment for cIAI","type":"EXPERIMENTAL"},{"label":"Meropenem as treatment for cIAI","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3, multicenter, prospective, randomized, double-blind, double dummy study of CXA-201 Intravenous (IV) infusions (1500mg q8h) and metronidazole (500mg q8h) versus meropenem (1000mg q8h)for the treatment of adults with Complicated Intraabdominal Infections (cIAI).","primaryOutcome":{"measure":"The Percentage of Subjects With Clinical Outcome of Cure at the Test of Cure (TOC) Visit in the Microbiological Intent to Treat (MITT) Population","timeFrame":"TOC; 26-30 days after start of study drug administration","effectByArm":[{"arm":"CXA-201 and Metronidazole as Treatment for cIAI","deltaMin":83,"sd":null},{"arm":"Meropenem as Treatment for cIAI","deltaMin":87.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":10},"locations":{"siteCount":61,"countries":["United States","Argentina","Bulgaria","Chile","Croatia","Estonia","Germany","Hungary","Israel","Latvia","Lithuania","Moldova","Poland","Serbia","South Korea"]},"refs":{"pmids":["28464828","28446129","27999024","27139477","25670823"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":39,"n":482},"commonTop":["Nausea","Diarrhoea","Pyrexia","Vomiting","Insomnia"]}}